Champions Oncology (CSBR) Payables (2016 - 2025)
Historic Payables for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $6.0 million.
- Champions Oncology's Payables rose 2346.52% to $6.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $6.0 million, marking a year-over-year increase of 2346.52%. This contributed to the annual value of $4.2 million for FY2025, which is 2675.86% down from last year.
- Champions Oncology's Payables amounted to $6.0 million in Q4 2025, which was up 2346.52% from $4.8 million recorded in Q3 2025.
- Over the past 5 years, Champions Oncology's Payables peaked at $6.0 million during Q4 2025, and registered a low of $1.7 million during Q1 2021.
- For the 5-year period, Champions Oncology's Payables averaged around $4.2 million, with its median value being $4.6 million (2022).
- Its Payables has fluctuated over the past 5 years, first crashed by 3968.15% in 2021, then skyrocketed by 12700.04% in 2023.
- Quarter analysis of 5 years shows Champions Oncology's Payables stood at $3.5 million in 2021, then soared by 32.44% to $4.6 million in 2022, then decreased by 1.5% to $4.5 million in 2023, then rose by 7.01% to $4.9 million in 2024, then increased by 23.47% to $6.0 million in 2025.
- Its Payables was $6.0 million in Q4 2025, compared to $4.8 million in Q3 2025 and $4.2 million in Q2 2025.